Press Room

News / Nov 25, 2021

Watch Luís Portela on Procurement Leaders' Extraordinary Stories

Procurement Leaders invited our Procurement Director to explain how Hovione produced and offered sanitizing agent to the community.

In 2021, Procurement Leaders – a community that provides strategy development and peer-to-peer benchmarking for Chief Procurement Officers – decided to replace their World Procurement Awards with a one-off celebration: Extraordinary Stories. These stories, from organizations across the globe recognize how procurement has stepped up in times of strain to support business performance, protect local communities and save lives during the pandemic.

 

Luís Portela, Procurement Director at Hovione, was invited to tell Hovione’s extraordinary story through this period. In a short video he explains how we produced and supplied for free, sanitizing agents at a time where this was scarcely available and speculation drove prohibitive prices.

 

We adapted sectors of our industrial facilities to produce sanitizing agent and made it available for free to our Team Members at work and at home, as well as to healthcare and social supporting institutions. This was only possible with a team effort while we continued to produce medicines that save lives without disruptions.

 

Watch the video at Procurement Leaders.com

Learn more about our efforts in the article "Stepping up to the hand sanitizer shortage" by C&EN.

 

 

 

 

Also in the Press Room

See All

Integrated approach simplifies development, reduces risk, and supports scalable manufacturing. Hovione and Industrial Design Consultancy Ltd.’s (IDC) lead single-use nasal dry powder device is now available for commercial partnerships. Hovione and IDC have completed the device design and established initial device manufacturing and supply capability, enabling pharmaceutical partners to leverage existing capsule filling infrastructure. This approach simplifies development, reduces cost and risk, and helps shorten timelines to the clinic and commercialization. “This milestone marks an important step in the evolution of our collaboration with IDC — from device innovation to a fully integrated intranasal drug delivery platform,” said Márcio Temtem, Ph.D., Vice President, Strategic Business Management, Hovione. “As the industry looks for faster, more reliable ways to bring complex therapies to patients, integration becomes critical. By bringing together nasal particle engineering science, formulation manufacturing and filling, and device technologies into a single offering, we enable a more seamless and predictable development journey, accelerating the path to market for intranasal therapies.” The nasal delivery device enables broad and targeted nasal deposition flexibility while delivering maximum usability and reliability. With a patented design and manufacturing process established, the platform is available for partnering with pharmaceutical companies on an exclusive basis as part of Hovione’s integrated offering for inhalation and nasal drug development and manufacturing. Additionally, IDC’s Managing Director, Stephen Knowles Ph.D., said the companies are now “well-advanced” with the development of a multi-use device to support an even wider range of therapies and patient needs. Read the full article at ContractPharma.com    

Press Clipping

Hovione, IDC Launch Intranasal Drug Delivery Platform

May 07, 2026